Investment Summary

Signet Healthcare Partners Invests In Curida

On April 16, 2024, growth capital firm Signet Healthcare Partners invested in life science company Curida

Investment Highlights
  • This is Signet Healthcare Partners’ 12th transaction in the Life Science sector.
  • This is Signet Healthcare Partners’ 1st transaction in Norway.

Investment Summary
Date 2024-04-16
Target Curida
Sector Life Science
Investor(s) Signet Healthcare Partners
Deal Type Growth Capital
Advisor(s) DNB Markets (Financial)
Simonsen Vogt Wiig (Legal)

Target

Curida

Oslo, Norway
Curida offers contract development and manufacturing solutions to European pharmaceutical and biotech companies globally. Curida was founded in 2015 and is based in Oslo, Norway.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Signet Healthcare Partners

Investor Investor Investor Investor

Category Growth Capital Firm
Founded 1998
PE ASSETS 600M USD
Size Middle-Market
Type Sector Focused
DESCRIPTION

Signet Healthcare Partners is a growth capital firm focused on the healthcare sector. Specific areas of interest include specialty pharmaceuticals, pharmaceutical services, medical devices, and diagnostics. Signet will consider opportunities throughout North America and Europe and looks to commit $10 to $50 million per transaction. Signet Healthcare Partners was established in 1998 and is headquartered in New York, New York.

DEAL STATS #
Overall 15 of 15
Sector (Life Science) 12 of 12
Type (Growth Capital) 10 of 10
Country (Norway) 1 of 1
Year (2024) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-03-07 Paragonix Technologies

Waltham, Massachusetts, United States

Paragonix Technologies is a developer, manufacturer, and service provider in the organ transplant industry, establishing a novel approach to organ preservation. Paragonix Technologies provides Advanced Organ Preservation (“AOP”) devices that safeguard donor organs during the journey between donor and recipient patients. Paragonix Technologies is based in Waltham, Massachusetts.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-08-22 Paragonix Technologies

Waltham, Massachusetts, United States

Paragonix Technologies is a developer, manufacturer, and service provider in the organ transplant industry, establishing a novel approach to organ preservation. Paragonix Technologies provides Advanced Organ Preservation (“AOP”) devices that safeguard donor organs during the journey between donor and recipient patients. Paragonix Technologies is based in Waltham, Massachusetts.

Sell -
Mergr

Product

Company

Legal